Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Hydroxypinacolone retinoate is a potent anti-aging ingredient for skin that is more effective and less irritating than other forms of retinoids.

The treatment showed limited success in repigmenting hair for vitiligo-associated leukotrichia.

Alopecia areata cases in children are rising, especially in females and low-income regions, with a projected increase in China and decrease in the USA.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Older hair follicle stem cells have a reduced ability to renew themselves, leading to more hair loss.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Activating Nrf2 helps wounds heal faster by increasing hair follicle stem cells.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The meeting highlighted the importance of genetic testing and multidisciplinary approaches in pediatric dermatology.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Centipedegrass extract may promote hair growth by activating certain cell pathways.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.